Taxol Avastin Liver Mets Breast Cancer

Featured Health Expert
78
EXPERT

FDA Takes Cautious Approach to Avastin as Metastatic Breast Cancer Treatment

When the news broke December 5 that an FDA expert panel had voted 5-4 to reject Avastin (bevacizumab) as an approved breast cancer treatment because of serious side effects, I experienced a moment of deep sadness, as well as some frustration. Avastin, a cutting-edge, “targeted drug” therapy for women with metastatic breast cancer, has been shown (when taken with chemotherapy) to give these women an extra 5 1/2 months of time when their cancer doesn’t grow and spread. And when you have...

Read more

More information on "Taxol Avastin Liver Mets Breast Cancer"

From Our Experts

See more SharePosts »

From Our Sources

More on Breast Cancer »